2024
DOI: 10.1016/j.jconrel.2024.01.035
|View full text |Cite
|
Sign up to set email alerts
|

ATP-adenosine axis regulation combined with microneedle assisted photoimmunotherapy to boost the immunotherapy efficiency

Chaonan Shi,
Minglong Chen,
Xiaodie Li
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 45 publications
0
2
0
Order By: Relevance
“…22,23 In addition, PTT can trigger immunogenic cell death (ICD) in tumor cells. [24][25][26] The dying tumor cells would release damage-associated molecular patterns (DAMPs), e.g., adenosine triphosphate (ATP), calreticulin (CRT) and high mobility group box 1 (HMGB1), which could subsequently trigger the chain of immune responses. 27 Polydopamine (PDA) possesses favorable biocompatibility, high thermal stability and photothermal conversion efficiency, 28 which make it an excellent choice for the fabrication of photothermal agents.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…22,23 In addition, PTT can trigger immunogenic cell death (ICD) in tumor cells. [24][25][26] The dying tumor cells would release damage-associated molecular patterns (DAMPs), e.g., adenosine triphosphate (ATP), calreticulin (CRT) and high mobility group box 1 (HMGB1), which could subsequently trigger the chain of immune responses. 27 Polydopamine (PDA) possesses favorable biocompatibility, high thermal stability and photothermal conversion efficiency, 28 which make it an excellent choice for the fabrication of photothermal agents.…”
Section: Introductionmentioning
confidence: 99%
“…22,23 In addition, PTT can trigger immunogenic cell death (ICD) in tumor cells. 24–26 The dying tumor cells would release damage-associated molecular patterns (DAMPs), e.g. , adenosine triphosphate (ATP), calreticulin (CRT) and high mobility group box 1 (HMGB1), which could subsequently trigger the chain of immune responses.…”
Section: Introductionmentioning
confidence: 99%